NASDAQ:DH - Nasdaq - US24477E1038 - Common Stock - Currency: USD
2.63
-0.14 (-5.05%)
The current stock price of DH is 2.63 USD. In the past month the price decreased by -49.62%. In the past year, price decreased by -68.99%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 35.72 | 38.34B | ||
DOCS | DOXIMITY INC-CLASS A | 51.53 | 12.38B | ||
WAY | WAYSTAR HOLDING CORP | N/A | 7.00B | ||
CERT | CERTARA INC | 25.82 | 1.87B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 14.06 | 1.77B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.62B | ||
SDGR | SCHRODINGER INC | N/A | 1.53B | ||
PHR | PHREESIA INC | N/A | 1.41B | ||
EVH | EVOLENT HEALTH INC - A | 14.11 | 1.09B | ||
HSTM | HEALTHSTREAM INC | 49.86 | 1.00B | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 979.67M | ||
SLP | SIMULATIONS PLUS INC | 70.8 | 568.95M |
Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. The company is headquartered in Framingham, Massachusetts and currently employs 830 full-time employees. The company went IPO on 2021-09-15. The Company’s solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. The company transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. All of its business is conducted through AIDH TopCo, LLC (Definitive OpCo).
DEFINITIVE HEALTHCARE CORP
492 Old Connecticut Path, Suite 401
Framingham MASSACHUSETTS US
CEO: Jason Krantz
Employees: 950
Company Website: https://ir.definitivehc.com/
Investor Relations: https://ir.definitivehc.com/
Phone: 15087204224
The current stock price of DH is 2.63 USD. The price decreased by -5.05% in the last trading session.
The exchange symbol of DEFINITIVE HEALTHCARE CORP is DH and it is listed on the Nasdaq exchange.
DH stock is listed on the Nasdaq exchange.
22 analysts have analysed DH and the average price target is 5 USD. This implies a price increase of 90.04% is expected in the next year compared to the current price of 2.63. Check the DEFINITIVE HEALTHCARE CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
DEFINITIVE HEALTHCARE CORP (DH) has a market capitalization of 407.60M USD. This makes DH a Small Cap stock.
DEFINITIVE HEALTHCARE CORP (DH) currently has 950 employees.
The Revenue of DEFINITIVE HEALTHCARE CORP (DH) is expected to decline by -5.91% in the next year. Check the estimates tab for more information on the DH EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
DH does not pay a dividend.
DEFINITIVE HEALTHCARE CORP (DH) will report earnings on 2025-05-05, after the market close.
The PE ratio for DEFINITIVE HEALTHCARE CORP (DH) is 7.51. This is based on the reported non-GAAP earnings per share of 0.35 and the current share price of 2.63 USD. Check the full fundamental report for a full analysis of the valuation metrics for DH.
The outstanding short interest for DEFINITIVE HEALTHCARE CORP (DH) is 4.58% of its float. Check the ownership tab for more information on the DH short interest.
ChartMill assigns a fundamental rating of 4 / 10 to DH. While DH seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months DH reported a non-GAAP Earnings per Share(EPS) of 0.35. The EPS increased by 16.67% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -37.92% | ||
ROE | -92.97% | ||
Debt/Equity | 0.52 |
ChartMill assigns a Buy % Consensus number of 75% to DH. The Buy consensus is the average rating of analysts ratings from 22 analysts.
For the next year, analysts expect an EPS growth of -13.07% and a revenue growth -5.91% for DH